还应关注生物科技公司(IBB),因为该组股票上涨了 2.6%。注意我们在八月中旬看到的走势,这轮上涨很大程度上归功于 Moderna 在 DNA 及其他领域的进展。我们看到整个板块在下跌之后出现了显著复苏,现在我们正处于恢复这一上升趋势的边缘。
这是另一个我们会关注一些曾经人气下降、随后又重新出现的股票的领域。
Attention should also be paid to biotechnology companies ( IBB), as shares in this group rose by 2.6% . Note the dynamic we saw in mid- August, and much of this rise is due to Moderna's progress in DNA and other areas.
We have seen a remarkable recovery in the group as a whole after its decline, and we are now on the verge of restoring this upward trend. This is another area where we will take a look at some stocks that have declined in popularity and then reappeared.